Pain outcomes in persons with multiple sclerosis receiving S1PR modulators: A cross-sectional study
{{output}}
Background: The impact of disease-modifying therapies (DMT) on chronic pain in multiple sclerosis (MS) is poorly understood. Preclinical research suggests that modulation of sphingosine-1-phosphate pathways involved in inflammati... ...
